全文获取类型
收费全文 | 921篇 |
免费 | 96篇 |
出版年
2021年 | 12篇 |
2020年 | 12篇 |
2019年 | 13篇 |
2018年 | 17篇 |
2017年 | 25篇 |
2016年 | 10篇 |
2015年 | 31篇 |
2014年 | 32篇 |
2013年 | 46篇 |
2012年 | 59篇 |
2011年 | 64篇 |
2010年 | 35篇 |
2009年 | 39篇 |
2008年 | 42篇 |
2007年 | 48篇 |
2006年 | 41篇 |
2005年 | 45篇 |
2004年 | 33篇 |
2003年 | 38篇 |
2002年 | 39篇 |
2001年 | 34篇 |
2000年 | 36篇 |
1999年 | 24篇 |
1998年 | 15篇 |
1997年 | 7篇 |
1996年 | 10篇 |
1995年 | 9篇 |
1992年 | 15篇 |
1991年 | 6篇 |
1990年 | 10篇 |
1989年 | 9篇 |
1988年 | 12篇 |
1987年 | 14篇 |
1986年 | 13篇 |
1985年 | 7篇 |
1984年 | 4篇 |
1983年 | 7篇 |
1982年 | 8篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1977年 | 9篇 |
1976年 | 4篇 |
1975年 | 7篇 |
1973年 | 4篇 |
1972年 | 8篇 |
1970年 | 5篇 |
1968年 | 3篇 |
1966年 | 6篇 |
排序方式: 共有1017条查询结果,搜索用时 300 毫秒
991.
992.
Silvana Debernardi Harrison OBrien Asma S. Algahmdi Nuria Malats Grant D. Stewart Marija Pljea-Ercegovac Eithne Costello William Greenhalf Amina Saad Rhiannon Roberts Alexander Ney Stephen P. Pereira Hemant M. Kocher Stephen Duffy Oleg Blyuss Tatjana Crnogorac-Jurcevic 《PLoS medicine》2020,17(12)
BackgroundPancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with around 9% of patients surviving >5 years. Asymptomatic in its initial stages, PDAC is mostly diagnosed late, when already a locally advanced or metastatic disease, as there are no useful biomarkers for detection in its early stages, when surgery can be curative. We have previously described a promising biomarker panel (LYVE1, REG1A, and TFF1) for earlier detection of PDAC in urine. Here, we aimed to establish the accuracy of an improved panel, including REG1B instead of REG1A, and an algorithm for data interpretation, the PancRISK score, in additional retrospectively collected urine specimens. We also assessed the complementarity of this panel with CA19-9 and explored the daily variation and stability of the biomarkers and their performance in common urinary tract cancers.Methods and findingsClinical specimens were obtained from multiple centres: Barts Pancreas Tissue Bank, University College London, University of Liverpool, Spanish National Cancer Research Center, Cambridge University Hospital, and University of Belgrade. The biomarker panel was assayed on 590 urine specimens: 183 control samples, 208 benign hepatobiliary disease samples (of which 119 were chronic pancreatitis), and 199 PDAC samples (102 stage I–II and 97 stage III–IV); 50.7% were from female individuals. PDAC samples were collected from patients before treatment. The samples were assayed using commercially available ELISAs. Statistical analyses were performed using non-parametric Kruskal–Wallis tests adjusted for multiple comparisons, and multiple logistic regression. Training and validation datasets for controls and PDAC samples were obtained after random division of the whole available dataset in a 1:1 ratio. The substitution of REG1A with REG1B enhanced the performance of the panel to detect resectable PDAC. In a comparison of controls and PDAC stage I–II samples, the areas under the receiver operating characteristic curve (AUCs) increased from 0.900 (95% CI 0.843–0.957) and 0.926 (95% CI 0.843–1.000) in the training (50% of the dataset) and validation sets, respectively, to 0.936 in both the training (95% CI 0.903–0.969) and the validation (95% CI 0.888–0.984) datasets for the new panel including REG1B. This improved panel showed both sensitivity (SN) and specificity (SP) to be >85%. Plasma CA19-9 enhanced the performance of this panel in discriminating PDAC I–II patients from controls, with AUC = 0.992 (95% CI 0.983–1.000), SN = 0.963 (95% CI 0.913–1.000), and SP = 0.967 (95% CI 0.924–1.000). We demonstrate that the biomarkers do not show significant daily variation, and that they are stable for up to 5 days at room temperature. The main limitation of our study is the low number of stage I–IIA PDAC samples (n = 27) and lack of samples from individuals with hereditary predisposition to PDAC, for which specimens collected from control individuals were used as a proxy.ConclusionsWe have successfully validated our urinary biomarker panel, which was improved by substituting REG1A with REG1B. At a pre-selected cutoff of >80% SN and SP for the affiliated PancRISK score, we demonstrate a clinically applicable risk stratification tool with a binary output for risk of developing PDAC (‘elevated’ or ‘normal’). PancRISK provides a step towards precision surveillance for PDAC patients, which we will test in a prospective clinical study, UroPanc.Silvana Debernardi and colleagues establish a clinical risk score and a biomarker panel for early detection of pancreatic cancer. 相似文献
993.
Bacterial Community Structure of Acid-Impacted Lakes: What Controls Diversity? 总被引:1,自引:0,他引:1 下载免费PDF全文
994.
995.
996.
997.
998.
The immunogold staining technique was evaluated for use in the identification of lymphocyte subsets in bronchoalveolar lavage fluid. The results obtained compared favorably to the identification of lymphocytes by the E-rosette method, the acid alpha-naphthyl-acetate esterase (ANAE) stain and immunofluorescence microscopy. The main advantages of the immunogold staining method include improved cellular detail and the attainment of permanent preparations, allowing for reassessment, intralaboratory comparison and the performance of further histochemical techniques if desired. 相似文献
999.
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle 总被引:148,自引:0,他引:148
p105-RB is the product of the retinoblastoma tumor suppressor gene. It is a nuclear phosphoprotein hypothesized to act as an inhibitor of cellular proliferation, yet surprisingly it is present in actively dividing cells. To look for changes in p105-RB that may regulate its activity during the cell cycle, we generated synchronized cell populations and followed their progression through the cell cycle. p105-RB is synthesized throughout the cycle, but is phosphorylated in a phase-specific manner. In the G0 and G1 phases of the cell cycle, an unphosphorylated species of the protein is the only detectable form, whereas in the S and G2/M phases, multiple phosphorylated species of p105-RB are detected. 相似文献
1000.